Answers are grounded in this paper and cite their sources.
Insulin-like growth factor I is a human plasma peptide with strong homology to human proinsulin. Many lines of evidence suggest that somatomedin-C and insulin-like growth factor I are identical molecules. However, no structural data regarding the carboxy-terminal end of somatomedin-C has yet been produced. We report a region-specific immunoassay directed against the carboxy-terminal end of insulin-like growth factor I. Somatomedin-C and insulin-like growth factor I are indistinguishable in this region-specific immunoassay. Insulin-like activity II and multiplication stimulating activity show partial cross reaction in this immunoassay. This study provides the first evidence about the carboxy-terminal portion of somatomedin-C and re-emphasizes that somatomedin-C and insulin-like growth factor I should be considered identical molecules.
No takes yet. Share an insight, caveat, or question.
Hintz et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: